secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2022-11-21T23:59:59+00:00
Accession:  0000947871-22-001199
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health authorizes $10B share repurchase program; amends bylaws for universal proxy rules
--------------------------------------------------------------------------------

- Board approved new $10B repurchase program after exhausting 2021 authorization.
- Repurchases may occur via open market, private deals, accelerated share repurchase, or derivatives.
- Bylaws amended to mandate compliance with SEC Rule 14a-19 for director nominations and proxies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000094787122001199/0000947871-22-001199-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000094787122001199/ss1535680_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-22-001199

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer